Breaking News Instant updates and real-time market news.

BERY

Berry Global

$60.73

0.74 (1.23%)

08:31
01/12/18
01/12
08:31
01/12/18
08:31

Berry Global announces retirement of executive chairman Jonathan Rich

Berry Global Group announced that Jonathan Rich will retire as executive chairman and a Board member, and that the Board has unanimously elected CEO Thomas Salmon to succeed Rich as Chairman of the Board, each effective February 1, 2018. Salmon has served as a Board member since his appointment as CEO one year ago.

BERY Berry Global
$60.73

0.74 (1.23%)

09/08/17
KEYB
09/08/17
NO CHANGE
KEYB
Bemis takeout unlikely 'much above' $55 per share, says KeyBanc
After Bloomberg reported Australian-based packaging company Amcor is considering a takeover of Bemis (BMS), KeyBanc analyst Adam Josephson says he does expect any deal to come in "much above" $55 per share for Bemis. Berry Global (BERY) is the only U.S. packager that might consider a competing offer, Josephson tells investors in a research note. He notes that at Thursday's closing price, Bemis is trading at 10.5 times the consensus 2017 adjusted EBITDA estimate. A 20% premium to yesterday's closing price would imply a $51 price, the analyst adds. He thinks Amcor would have to pay north of that in a deal. A price of $55 per share, just above Bemis' all-time high price of $54 per share, would imply a 12.0 times multiple, which is "quite expensive" for the packaging sector, Josephson argues. He has a Sector Weight rating on Bemis.
11/17/17
BARD
11/17/17
NO CHANGE
Target $70
BARD
Outperform
Berry Global price target raised to $70 from $65 at Baird
Baird analyst Ghansham Panjabi raised his price target on Berry Global to $70 from $65 following Q4 results. The analyst said the company continues to execute on operations and the integration of AEP Industries while the announced Clopay acquisition has low risk from a synergy standpoint. He said volume growth remains the key for multiple expansion. Panjabi reiterated his Outperform rating on Berry Global shares.
11/20/17
RBCM
11/20/17
NO CHANGE
Target $69
RBCM
Outperform
Berry Global price target raised to $69 from $65 at RBC Capital
RBC Capital analyst Arun Viswanathan raised his price target on Berry Global to $69 and kept his Outperform rating. Viswanathan says that despite the volume decline -attributed to industry-wide processed food softness - and the EBITDA miss in Q4, conditions will improve into the second half of FY18 thanks to new wins in Consumer Packing business and easing comps in the Health, Hygiene, & Specialties segment.
11/21/17
RHCO
11/21/17
NO CHANGE
Target $69
RHCO
Buy
Berry Global price target raised to $69 from $65 at SunTrust
SunTrust analyst Jason Freuchtel raised his price target on Berry Global to $69 and kept his Buy rating after strong Q4 results showed better than expected free cash flows. Freuchtel says he expects the company to continue to drive higher FCF due to inorganic earnings contribution and synergy capture. The analyst also speculates that Berry Global could initiate a dividend payout in 2018 as well as announce more acquisitions in addition to the recent Clopay deal.

TODAY'S FREE FLY STORIES

JPM

JPMorgan

$107.58

-0.6 (-0.55%)

07:18
06/20/18
06/20
07:18
06/20/18
07:18
Periodicals
JPMorgan's Dimon speaks against Trump policy of separating families, CNBC says »

JPMorgan CEO Jamie Dimon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jul

  • 12

    Oct

ORCL

Oracle

$46.29

-0.25 (-0.54%)

07:17
06/20/18
06/20
07:17
06/20/18
07:17
Downgrade
Oracle rating change  »

Oracle downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$197.46

-0.84 (-0.42%)

07:16
06/20/18
06/20
07:16
06/20/18
07:16
Recommendations
Facebook analyst commentary  »

Facebook Messenger…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$258.35

-5.295 (-2.01%)

07:16
06/20/18
06/20
07:16
06/20/18
07:16
Recommendations
FedEx analyst commentary  »

FedEx results 'good…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

AAL

American Airlines

$41.51

-0.93 (-2.19%)

07:15
06/20/18
06/20
07:15
06/20/18
07:15
Periodicals
American Airlines prepares for management-level layoffs, buyouts, CNBC reports »

American Airlines told…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

MERC

Mercer

$16.15

-0.25 (-1.52%)

07:15
06/20/18
06/20
07:15
06/20/18
07:15
Upgrade
Mercer rating change  »

Mercer upgraded to Buy on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NGD

New Gold

$2.09

(0.00%)

07:15
06/20/18
06/20
07:15
06/20/18
07:15
Downgrade
New Gold rating change  »

New Gold downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$57.43

0.22 (0.38%)

07:14
06/20/18
06/20
07:14
06/20/18
07:14
Recommendations
Starbucks analyst commentary  »

UBS keeps Buy rating, $66…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

NKE

Nike

$74.27

-1.33 (-1.76%)

07:11
06/20/18
06/20
07:11
06/20/18
07:11
Recommendations
Nike analyst commentary  »

Nike price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

MTN

Vail Resorts

$280.81

-4.21 (-1.48%)

07:11
06/20/18
06/20
07:11
06/20/18
07:11
Initiation
Vail Resorts initiated  »

Vail Resorts initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POOL

Pool Corp.

$154.54

0.52 (0.34%)

07:10
06/20/18
06/20
07:10
06/20/18
07:10
Initiation
Pool Corp. initiated  »

Pool Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLNT

Planet Fitness

$45.11

-0.5 (-1.10%)

07:09
06/20/18
06/20
07:09
06/20/18
07:09
Initiation
Planet Fitness initiated  »

Planet Fitness initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLS

Nautilus

$16.40

-0.1 (-0.61%)

07:09
06/20/18
06/20
07:09
06/20/18
07:09
Initiation
Nautilus initiated  »

Nautilus initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$143.92

38.44 (36.44%)

07:09
06/20/18
06/20
07:09
06/20/18
07:09
Recommendations
Sarepta analyst commentary  »

Sarepta price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

GLOB

Globant

$56.99

-0.01 (-0.02%)

07:09
06/20/18
06/20
07:09
06/20/18
07:09
Syndicate
Globant announces commencement of 5.8M share secondary offering »

WPP plc (WPP) and Globant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

FOXF

Fox Factory

$44.10

0.2 (0.46%)

07:09
06/20/18
06/20
07:09
06/20/18
07:09
Initiation
Fox Factory initiated  »

Fox Factory initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSGX

Histogenics

$2.74

-0.13 (-4.53%)

07:06
06/20/18
06/20
07:06
06/20/18
07:06
Recommendations
Histogenics analyst commentary  »

Histogenics Phase 3 study…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDRBF

Bombardier

$0.00

(0.00%)

, DAL

Delta Air Lines

$53.78

-1.025 (-1.87%)

07:06
06/20/18
06/20
07:06
06/20/18
07:06
Hot Stocks
Delta Air Lines orders 20 Bombardier CRJ900 valued at approx. $961M »

Bombardier Commercial…

BDRBF

Bombardier

$0.00

(0.00%)

DAL

Delta Air Lines

$53.78

-1.025 (-1.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 29

    Jun

APEN

Apollo Endosurgery

$5.60

-0.3 (-5.08%)

07:06
06/20/18
06/20
07:06
06/20/18
07:06
Syndicate
Apollo Endosurgery 3.747M share Spot Secondary priced at $5.50 »

Craig-Hallum acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIG

AIG

$55.50

-0.065 (-0.12%)

07:05
06/20/18
06/20
07:05
06/20/18
07:05
Hot Stocks
AIG acquires Ellipse from Munich Re »

AIG and Munich Re…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUK

Duke Energy

$75.67

1.28 (1.72%)

07:05
06/20/18
06/20
07:05
06/20/18
07:05
Upgrade
Duke Energy rating change  »

Duke Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WGO

Winnebago

$40.40

-0.35 (-0.86%)

07:04
06/20/18
06/20
07:04
06/20/18
07:04
Earnings
Winnebago reports Q3 EPS $1.02, consensus 91c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

07:04
06/20/18
06/20
07:04
06/20/18
07:04
General news
MBA Mortgage Applications Composite Index data reported »

Week of 6/15 MBA Mortgage…

SPX

S&P 500

$0.00

(0.00%)

07:04
06/20/18
06/20
07:04
06/20/18
07:04
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRX

Amneal Pharmaceuticals

$18.83

-0.69 (-3.53%)

07:03
06/20/18
06/20
07:03
06/20/18
07:03
Hot Stocks
Amneal announces patent litigation settlement agreement with Actavis »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.